Drug Monograph
Full clinical overview, indications, dosage references & safety notes.
Overview
Cetirizine is a second-generation antihistamine commonly used in veterinary medicine for the management of allergic conditions in dogs and cats. It acts primarily as a selective peripheral H1 receptor antagonist and helps reduce the effects of histamine released during allergic reactions.
Compared with first-generation antihistamines, cetirizine causes minimal sedation because it poorly penetrates the blood–brain barrier. It also lacks significant anticholinergic or serotonergic effects, making it generally well tolerated in small animals.
Cetirizine is administered orally and is typically used as an adjunctive therapy for allergic and pruritic conditions. Clinical response can vary between patients, and antihistamines are often most effective when used as preventive therapy before exposure to allergens.
Indications
- Allergic and pruritic conditions: Cetirizine may be used as an adjunctive therapy for histamine-mediated allergic reactions in dogs and cats.
- Respiratory allergies: May help reduce signs such as sneezing, nasal discharge, and ocular discharge associated with allergic disease.
- Urticaria and insect bite hypersensitivity: Can be used to help control allergic skin reactions caused by insect bites or environmental allergens.
- Allergic skin disease in cats: Some cats with allergic dermatitis may experience reduction in pruritus when treated with cetirizine.
- Adjunct therapy in canine allergic disease: Antihistamines like cetirizine may be used as part of a multimodal approach to allergic conditions, although response can vary between individuals.
Dosage (Reference)
Dog
In dogs, cetirizine is used extra-label as an oral antihistamine for management of allergic pruritus and other histamine-mediated conditions. Response varies among individuals, and trial therapy is often required to determine effectiveness.
| Clinical use | Route | Dose | Frequency | Notes |
|---|---|---|---|---|
| Pruritus associated with atopic dermatitis | PO | 1–4 mg/kg | — | Once daily; may be given with or without food. |
• Cetirizine is typically used as preventive therapy and should be administered daily before allergic flare-ups occur.
• Reduced clinical response has been reported in some dogs receiving lower doses (≈1 mg/kg once daily).
• Antihistamine therapy often requires a trial period of 1–2 weeks to determine individual effectiveness.
• Response varies widely among dogs and may be improved when used as part of a multimodal allergy management plan.
Cat
In cats, cetirizine is used extra-label as an antihistamine for management of allergic skin disease and pruritus. Recommended dosages vary, and both fixed-dose and weight-based dosing regimens have been reported.
| Clinical use | Route | Dose | Frequency | Notes |
|---|---|---|---|---|
| Adjunctive treatment of pruritus (open trial) | PO | 5 mg/cat | — | Once daily; pruritus reduction reported in some cats. |
| Adjunctive treatment of allergic pruritus | PO | 0.5–1 mg/kg | — | Every 12–24 hours. |
| Alternative fixed-dose regimen | PO | 2.5–5 mg/cat | — | Every 12–24 hours. |
• Both fixed dosing (mg/cat) and weight-based dosing (mg/kg) regimens are used clinically.
• Treatment response can vary, and cetirizine may not significantly reduce pruritus in all cats with allergic skin disease.
• As with other antihistamines, a trial period of approximately 1–2 weeks is often used to determine individual effectiveness.
Warnings and Precautions
- Hypersensitivity: Cetirizine should not be used in animals with known hypersensitivity to cetirizine or related antihistamines such as hydroxyzine.
- Renal or hepatic disease: Dose adjustment or cautious use may be advisable in animals with severe kidney or liver dysfunction because elimination of the drug may be reduced.
- Combination human products: Many over-the-counter products contain additional ingredients such as decongestants (e.g., pseudoephedrine) that are unsafe for animals. Only single-ingredient cetirizine products should be used.
- Toxic excipients: Some liquid or orally disintegrating human formulations may contain ingredients such as propylene glycol or xylitol, which can be harmful to cats and dogs respectively.
- Pregnancy and lactation: Safety has not been firmly established in veterinary patients. Use only when potential benefits outweigh potential risks to offspring.
Drug Interactions
- CNS depressants (e.g., sedatives, benzodiazepines, opioids): Concurrent use may increase the risk of additive sedation or central nervous system depression.
- P-glycoprotein substrate drugs: Cetirizine may inhibit P-glycoprotein transporters, potentially increasing exposure to drugs such as cyclosporine, digoxin, or vincristine. Monitoring may be advisable when these drugs are used together.
- Ivermectin: Administration prior to cetirizine has been shown in some species to increase cetirizine exposure and elimination half-life, although the clinical significance remains uncertain.
Side Effects & Overdose
Side Effects
- Gastrointestinal effects: Vomiting or hypersalivation may occur after oral administration.
- Sedation: Mild drowsiness or somnolence may occasionally occur, particularly at higher doses.
- Behavioral changes: Some animals may show mild lethargy or reduced activity.
- Hypersensitivity reactions (rare): Allergic reactions may occur but are uncommon.
Overdose
- Neurologic signs: Excessive doses may lead to hyperactivity, lethargy, or altered behavior.
- Autonomic effects: Vomiting, panting, mydriasis, or tachycardia may occur in overdose situations.
- Combination product toxicity: Products containing additional ingredients such as pseudoephedrine may result in more severe toxicity.
- Treatment: Management is primarily supportive and focuses on controlling neurologic or gastrointestinal symptoms.
Key Notes
- Cetirizine is a second-generation antihistamine with minimal sedative effects compared with older antihistamines.
- It is an active metabolite of hydroxyzine with selective peripheral H1 receptor blockade.
- Antihistaminic effects typically last approximately 24 hours after oral administration.
- Cetirizine has minimal anticholinergic activity, which contributes to its favorable safety profile.
- Tolerance to its antihistamine effects appears to be uncommon with repeated use.
